A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
Travera Inc
National Institutes of Health Clinical Center (CC)
Bayer
Actuate Therapeutics Inc.
AstraZeneca
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Institut Bergonié
Aveni Foundation
ViroMissile, Inc.
Dana-Farber Cancer Institute
Essen Biotech
Angiex, Inc.
St. Jude Children's Research Hospital
MacroGenics
City of Hope Medical Center
University of Nebraska
Adela, Inc
Memorial Sloan Kettering Cancer Center
Var2 Pharmaceuticals
Mayo Clinic
Degron Therapeutics Co.
Bristol-Myers Squibb
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
AVM Biotechnology Inc
City of Hope Medical Center
Washington University School of Medicine
GONGCHU Biotechnology Co., Ltd
Sensei Biotherapeutics, Inc.
Lantheus Medical Imaging
Jonsson Comprehensive Cancer Center
Azienda Ospedaliera di Padova
University of Pittsburgh
NextPoint Therapeutics, Inc.
Cancer Research UK
OncoC4, Inc.
ADC Therapeutics S.A.
Gustave Roussy, Cancer Campus, Grand Paris
Tempus AI
Esperas Pharma Inc.
Elevation Oncology
Stanford University
Labcorp Corporation of America Holdings, Inc
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
National Cancer Institute (NCI)
Stanford University
Cybrexa Therapeutics